Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

The goal of this study is to genrate evidence on long-term effectiveness and safety of SKYTROFA (lonapegsomatropin) in patients with growth hormone deficiency under routine clinical care

Participants needed: 900
Trial details
Biological sex: AllType: ObservationalSponsor: Ascendis Pharma Endocrinology Division A/SUpdated: Apr 21, 2026Locations: 27Duration: 5 Years
Eligibility criteria

Patients who are on treatment with SKYTROFA (lonapegsomatropin) [+2]

Patients participating in any interventional clinical study

Status: Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

The goal of this study is to further characterise the potential long-term safety risks of lonapegsomatropin in patients treated with lonapegsomatropin under real-world conditions in the post-marketing setting.

Participants needed: 500
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Ascendis Pharma Endocrinology Division A/SUpdated: Feb 4, 2026Locations: 27
Eligibility criteria

Paediatric patients with GHD who are on treatment with lonapegsomatropin [+3]

Patients participating in any interventional clinical trial for short stature [+6]